Breast Care

Papers
(The median citation count of Breast Care is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response88
Palbociclib: Neue 5-Jahres-OS-Daten aus RCT bei HR+/HER2– aBC50
Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI)46
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes21
First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center19
PharmaNews18
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus18
Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer16
Erratum16
ABC7 Consensus: Assessment by a German Group of Experts16
Kombinationstherapie bei HER2+ mBC16
Front & Back Matter15
Junge Patientinnen mit frühem HER2-positivem Brustkrebs14
A Response and Discussion with Respect to Gulcelik’s Study in Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment13
Impact of Diabetes on Patient Outcomes in Breast Cancer Patients12
Prepubertal Idiopathic Unilateral Gynecomastia: Case Report and Literature Review11
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 201811
Insights from ASCO 202310
Menopausal Hormone Therapy and the Breast: A Review of Clinical Studies9
PharmaNews8
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti7
Is 9-G DBT-Guided Vacuum-Assisted Breast Biopsy Sufficient to Completely Remove T1 Breast Cancers (below 20 mm)? Analysis of 146 Patients with Histology as Reference Standard7
Risk Factors for Idiopathic Granulomatous Mastitis Recurrence after Patient-Tailored Treatment: Do We Need an Escalating Treatment Algorithm?7
Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia7
Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis7
Biomarkers: Which Ones Do We Really Need Today?7
Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis7
Concerning de Oliveira-Junior et al. “Oncoplastic Surgery in Breast-Conserving Treatment: Patient Profile and Impact on Quality of Life.” Breast Care. 2021;16(3):243–2537
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer7
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period7
Contents Vol. 19, 20246
Long-Term Results of the TARGIT-A Trial: More Questions than Answers6
Translating Evidence into Practice: A Review of Clinical Practice and Outcomes following the Adoption of an Early Post-Mastectomy Discharge Protocol in a Nigerian Hospital6
The Role of High Intensity Focused Ultrasound in the Treatment of Fibroadenomas: A Systematic Review6
Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review5
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis5
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20235
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20235
PharmaNews5
Retrospective Impact of COVID-19 Pandemic on Primary Breast Cancer Care5
Expert Discussion: ESMO 20244
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience4
Vitamin D and Breast Cancer Risk: Evaluating the Association and Effective Risk Reduction4
Front & Back Matter4
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative R4
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer4
PharmaNews4
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20224
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis4
Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment4
Front & Back Matter4
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?3
First-in-Class-Therapie mit Sacituzumab Govitecan3
Higher CD1a Levels Correlate with PD-L1 Expression and Predict Worse Overall Survival in Triple-Negative Breast Carcinoma3
PharmaNews3
PharmaNews3
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?3
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)3
Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis3
Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer3
News from the San Antonio Breast Cancer Symposium 20223
Front & Back Matter3
Expert Discussion: SABCS 20213
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer – Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)3
Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure3
Prediction of Cardiac Toxicity by Measurement of Coronary Artery Calcium Scoring Method Using Chest Computed Tomography in Early Breast Cancer Patients Treated with Trastuzumab2
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts2
PharmaNews2
Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study2
Front & Back Matter2
Acknowledgement to Reviewers2
Quality Analysis of YouTube Videos Presenting Shoulder Exercises after Breast Cancer Surgery2
Clinical Axillary Staging in Breast Cancer Patients Using Ultrasound Imaging2
Front & Back Matter2
Acknowledgement to Reviewers2
The Impact of Breast Awareness on the Early Detection of Breast Cancer in Young Women: A Systematic Review2
Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants2
Expert Discussion: HER2-Positive Breast Cancer2
Expert Discussion: ASCO 20212
Front & Back Matter2
Society Bulletins2
Innovative Standards in Surgery of the Breast after Neoadjuvant Systemic Therapy2
HER2-Low Breast Cancer: Where Are We?2
Front & Back Matter2
PharmaNews2
Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?2
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer2
Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy2
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”2
Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution2
PharmaNews2
A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer2
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions2
Front & Back Matter2
Treatment of Luminal Metastatic Breast Cancer beyond CDK4/6 Inhibition: Is There a Standard of Care in Clinical Practice?2
Breast Reconstruction: Necessity for Further Standardization of the Current Surgical Techniques Attempting to Facilitate Scientific Evaluation and Select Tailored Individualized Procedures Optimizing 1
Effects and Risks of Hormonal Therapy before and after BC Therapy1
PharmaNews1
PharmaNews1
PharmaNews1
Selective Extirpation of Tattooed Lymph Node in Combination with Sentinel Lymph Node Biopsy in the Management of Node-Positive Breast Cancer Patients after Neoadjuvant Systemic Therapy1
Predictors for Upgrade to Breast Cancer in Patients with B3 Lesions Diagnosed by Core Biopsy: A Retrospective Cohort Study1
PharmaNews1
Patient-Reported Outcomes in Free-Flap Breast Reconstructive Surgery over Time (PRO-BREST)1
Budget Impact of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany1
Front & Back Matter1
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries1
PharmaNews1
PharmaNews1
Luminal Metastatic Breast Cancer: Current Concepts and Future Approaches1
Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systemati1
<i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy1
Targeted Axillary Dissection after Chemotherapy: Feasibility Study with Clip and Carbon Dye Tattoo – Neotarget Trial1
A Second Ductoscopy Procedure in Patients with Recurrent and Persistent Pathological Nipple Discharge1
Sacituzumab Govitecan – hoch effektiv1
Front & Back Matter1
Acknowledgement to Reviewers1
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation1
Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy1
Evaluation of the Effect of Axillary Radiotherapy Dose and the Development of Lymphedema in Breast Cancer Patients1
Expert Discussion: ASCO 20221
Society Bulletins1
Intention to Undergo Clinical Breast Examination and Its Associated Factors among Women Attending Rural Primary Healthcare Facilities in South Central Ethiopia1
Erratum1
Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer1
Front & Back Matter1
Pushing the Limits of Breast-Conserving Surgery with Extreme Oncoplasty0
PharmaNews0
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database0
ADC-basierte Therapie und Radiatio0
Fokus-Änderung auf HER2-Status beim mBC0
Low-Dose Methotrexate Use in Idiopathic Granulomatous Mastitis: An Alternative Treatment Method0
Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Canc0
Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria0
Expert Discussion: Highlights from the San Antonio Breast Cancer Symposium, San Antonio, December 8–11, 20200
From <b><i>BRCA1</i></b> to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes0
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Muta0
Breast Cancer Outcome: What Have We Achieved0
Assessment of MRI-Detected Breast Lesions: A Benign Correlate on Second-Look Ultrasound Can Safely Exclude Malignancy0
Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers0
Front & Back Matter0
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20240
The <b><i>CHEK2</i></b>*1100delC Mutation and Adolescent Breast Cancer: A Case Report of Breast Cancer in a 19-Year-Old and a Review of the Literature0
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study0
Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment: Long-Term Outcomes0
St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer0
Ultrasound Measurement of the Distance between the Breast Tumor and the Skin: A Cut-Off Value for Safe Skin Preservation – Diagnostic Accuracy Study0
Long-Term Outcome Analysis and Technical Refinements after Autologous Breast Reconstruction with PAP Flap: What We Have Learnt0
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study0
Effects of Diet after Early Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Clinical Trials0
PharmaNews0
Management von Antikörper-Wirkstoff-Konjugaten bei mBC0
Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer0
PharmaNews0
Are Diagnostic Delays Associated with Distress in Breast Cancer Patients?0
Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study0
Diffusion-Weighted Imaging of Different Breast Cancer Molecular Subtypes: A Systematic Review and Meta-Analysis0
Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer0
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)0
The Role of Social Media and Breast Cancer: How Does It Impact Patients?0
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping0
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20220
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20240
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer0
Awareness and Availability of Routine Germline <b><i>BRCA1/2</i></b> Mutation Testing in Patients with Advanced Breast Cancer in Germany0
Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer0
Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer: Transforming Books into Data0
Expert Discussion: Immunotherapy in Breast Cancer – Ready for Prime Time?0
Evolution of HER2 Targeting in Metastatic Breast Cancer0
Ärzt*in-Patient*in-Perspektive: Rezidivrisiko bei Brustkrebs0
Innovative Standards in Oncoplastic Breast Conserving Surgery: From Radical Mastectomy to Extreme Oncoplasty0
Quality and Quantity: How to Organize a Countrywide Genetic Counseling and Testing0
Clinical Importance of PGRMC1 in Hormone Responsive Breast Cancer0
The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study0
Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report0
Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast0
Treatment Strategy for Patients with HR-Positive HER2-Negative Metastatic Breast Cancer That Progressed on CDK4/6 Inhibitors0
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20210
Is Anti-Müllerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?0
Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection0
When Is Sentinel Node Biopsy Indicated in High-Risk Ductal Carcinoma in situ? Four Hundred Sixty-Eight Cases from Three Institutions0
Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases0
Erratum0
Breast Augmentation with Autologous Fat Grafting Immediately after Removal of Polyacrylamide Hydrogel and Fibrotic Capsule in 162 Patients0
Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer0
Expert Discussion: Ductal Carcinoma in situ0
Genetic Testing in Breast Cancer: New Standards of Care0
Clinical Outcomes in Breast Cancer Patients with HER2-Positive, Node-Negative Tumors (≤3 cm)0
New Media Platforms for Teaching and Networking: Emerging Global Opportunities for Breast Surgeons0
Current Evolutions in Axillary Management0
Interview ABC7: Bridging the Gap0
Contents Vol. 17, 20220
Contents Vol. 16, 20210
Sacituzumab govitecan: Trop-2 als Target0
App-Based Lifestyle Coaching (PINK!) Accompanying Breast Cancer Patients and Survivors to Reduce Psychological Distress and Fatigue and Improve Physical Activity: A Feasibility Pilot Study0
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy0
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients0
Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature0
The Role of Social Media in Breast Cancer Care and Survivorship: A Narrative Review0
CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis0
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer0
Expert Discussion: Predictive Markers0
Review Article a Multidisciplinary Evaluation for Advanced Supportive Care of Breast Cancer Patients0
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib0
ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group0
ABC6 Consensus: Assessment by a Group of German Experts0
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer0
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences0
Patient Satisfaction, Esthetic Outcome, and Quality of Life in Oncoplastic and Reconstructive Breast Surgery: A Single Center Experience0
PharmaNews0
37. Annual Meeting of the Austrian Society of Senology. Vienna, Austria, Sept. 8–9 2023. Abstracts0
Tamoxifen Treatment for Pubertal Gynecomastia: When to Start and How Long to Continue0
A Preliminary Study of Ultrasound-Guided Microwave Ablation for Nonpuerperal Mastitis Treatment0
Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?0
Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study0
False Negativity of Targeted Axillary Dissection in Breast Cancer0
Expert Discussion: Hypofractionated Radiation Therapy – Standard for All Indications?0
Acupuncture for Aromatase Inhibitor-Induced Arthralgia in Breast Cancer: An Umbrella Review0
Routine Preoperative Nutritional Optimization Not Required in Patients Undergoing Breast Reconstruction0
Exploring the Impact of Sarcopenia on Mortality in Breast Cancer Patients: A Comprehensive Systematic Review and Meta-Analysis0
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABC0
Nationwide Survey of German Outpatient Gynecologic Oncology Practices during the Coronavirus Disease 2019 Pandemic: Reactions to the First Wave and Future Perspectives0
Trastuzumab-Deruxtecan: Neue Ära bei HER2-low mBC0
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level0
Quality of Life Effects of an Oral Fixed Combination of Netupitant and Palonosetron in Chemotherapy-Induced Nausea and Vomiting Prevention: Real-World Evidence in Patients with Breast Cancer Receiving0
Gonadotropin-Releasing Hormone Agonists during Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients with Breast Cancer: A Systematic Review and Meta-0
Contents Vol. 18, 20230
Resistance Exercise for Breast Cancer Patients? Evidence from the Last Decade0
Mammakarzinom: Phesgo im häuslichen Umfeld0
Fifteen Years of <b><i>Breast Care</i></b>0
What Has Changed in Patients Aged 65 and over Diagnosed with Breast Cancer during the COVID-19 Pandemic: A Single-Center Experience0
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer – A Brief Summary of the Consensus Discussion0
CDK4/6-Inhibitoren: Neue Daten vom ESMO und ASCO0
Acknowledgement to Reviewers0
Risk and Survival of Third Primary Cancers in a Population-Based Cohort of Breast Cancer Patients0
PharmaNews0
Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience0
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors0
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference0
Oncoplastic Breast Conserving Surgery: Is There a Need for Standardization? Results of a Nationwide Survey0
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation0
Breast-Conserving Surgery with Immediate Partial Breast Reconstruction by Using Pedicled Thoracodorsal Artery Perforator Flap: A 7-Year Follow-Up of 50 Women0
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases0
The Role of 18F-FDG PET/CT in Predicting the Neoadjuvant Treatment Response in Patients with Locally Advanced Breast Cancer0
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)0
Augmented Reality in Breast Surgery Education0
Comparing the Efficacy of Intralesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis: Insights from a Single-Center Experience0
Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-670
Primary Prevention and Early Detection of Hereditary Breast Cancer0
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20210
0.054332971572876